Valuation: Cegedim

Market Cap 15Cr 17Cr 14Cr 13Cr 24Cr 1.61TCr 24Cr 160.69Cr 63Cr 807.04Cr 64Cr 62Cr 2.67TCr P/E 2026 *
7x
P/E 2027 * 5.34x
Enterprise Value 31Cr 36Cr 29Cr 26Cr 50Cr 3.39TCr 51Cr 338.36Cr 132.67Cr 1.7TCr 133.99Cr 131.02Cr 5.62TCr EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-56.91%
1 week+19.82%
Current month+19.35%
1 month+15.28%
3 months+1.25%
6 months-8.65%
Current year-9.33%
1 week 10.18
Extreme 10.18
12.15
1 month 10.12
Extreme 10.12
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
21.2
5 years 8.6
Extreme 8.6
29
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+19.82% - - 17Cr
-0.93%+20.37%-42.82%+26.17% 42TCr
+1.12%+6.29%-30.84%+39.24% 22TCr
-0.78%+5.97%-36.50%+6.25% 12TCr
-2.47%+4.14%-33.34%+16.95% 4.86TCr
+0.74%+2.30%-74.73%+160.95% 3.75TCr
+4.26%-18.31%-19.80%+29.79% 2.26TCr
+2.93%+7.61%-29.41%+73.83% 1.96TCr
-2.06%+0.34%-30.47%+5.04% 1.39TCr
+0.01%+0.58%-29.12%+89.61% 1.33TCr
Average -5.83%+3.07%-36.34%+49.76% 10.22TCr
Weighted average by Cap. -0.81%+11.98%-38.65%+33.40%

Financials

2026 *2027 *
Net sales 66Cr 76Cr 61Cr 57Cr 106.76Cr 7.25TCr 107.98Cr 722.7Cr 283.38Cr 3.63TCr 286.19Cr 279.83Cr 12TCr 68Cr 79Cr 64Cr 59Cr 110.72Cr 7.52TCr 111.99Cr 749.55Cr 293.9Cr 3.76TCr 296.82Cr 290.23Cr 12TCr
Net income 2.13Cr 2.46Cr 1.99Cr 1.83Cr 3.45Cr 234.12Cr 3.49Cr 23Cr 9.15Cr 117.22Cr 9.24Cr 9.04Cr 387.94Cr 2.8Cr 3.24Cr 2.61Cr 2.4Cr 4.53Cr 307.77Cr 4.58Cr 31Cr 12Cr 154.09Cr 12Cr 12Cr 509.97Cr
Net Debt 16Cr 19Cr 15Cr 14Cr 26Cr 1.78TCr 27Cr 177.68Cr 70Cr 892.37Cr 70Cr 69Cr 2.95TCr 13Cr 15Cr 12Cr 11Cr 22Cr 1.47TCr 22Cr 146.56Cr 57Cr 736.07Cr 58Cr 57Cr 2.44TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.68EUR
Average target price
15.50EUR
Spread / Average Target
+45.13%

Quarterly revenue - Rate of surprise